NORWICH – Christopher R. Calhoun, president of OSG Norwich Pharmaceuticals, today announced that the company has been purchased by AFI Partners, a private equity firm based in New York City.

Upon completion of the sale, the company will be named “Norwich Pharmaceuticals, Inc.” Operations at the North Norwich manufacturer will continue uninterrupted; the current leadership team and employees will remain with the new company.

“We certainly expect continued employment levels. The rest depends on our ability to keep attracting new customers,” Calhoun said.